Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Metastatic Spread
100%
Pancreatic Cancer
100%
Gemcitabine
100%
Tumor Progression
100%
Notch Signaling Pathway
100%
Pathway-targeted Therapy
100%
Tumor Metastatic
100%
PF-03084014
87%
Pancreatic Ductal Adenocarcinoma
50%
Cancer Stem Cells
37%
Tumor Regression
25%
Tumor
12%
Attenuation
12%
Tumor Cells
12%
Angiogenesis
12%
In(III)
12%
Clinical Trials
12%
Well-defined
12%
Secretase
12%
Tumor Targeting
12%
Highly Aggressive
12%
Preclinical Data
12%
Tumor Cell Proliferation
12%
Primary Tumor Growth
12%
Antitumor Activity
12%
Human Malignancies
12%
Apoptosis Inhibition
12%
Pancreatic Tumor
12%
Drug Treatment
12%
Combination Therapy
12%
Growth Curve
12%
Best Response
12%
Notch1
12%
Cancer Xenograft
12%
Constitutive Activation
12%
Apoptosis Induction
12%
Intracellular Domain
12%
Hes1
12%
Notch Signaling
12%
Xenograft Model
12%
Inpatient Treatment
12%
Metastatic Dissemination
12%
CD24
12%
CD44+
12%
Resilient
12%
ALDH+
12%
Orthotopic Model
12%
Tumor Regrowth
12%
Notch Targets
12%
In Vivo Therapeutic Effect
12%
β-secretase Inhibitors
12%
Pharmacology, Toxicology and Pharmaceutical Science
Gemcitabine
100%
Pancreas Cancer
100%
Tumor Growth
100%
Neoplasm
62%
Pancreas Adenocarcinoma
50%
Malignant Neoplasm
37%
Tumor Regression
25%
Secretase
25%
Primary Tumor
12%
Clinical Trial
12%
Pharmacotherapy
12%
Therapeutic Effect
12%
Combination Therapy
12%
Pancreas Tumor
12%
Minoxidil
12%